191 related articles for article (PubMed ID: 31300419)
21. The genetic landscape of mutations in Burkitt lymphoma.
Love C; Sun Z; Jima D; Li G; Zhang J; Miles R; Richards KL; Dunphy CH; Choi WW; Srivastava G; Lugar PL; Rizzieri DA; Lagoo AS; Bernal-Mizrachi L; Mann KP; Flowers CR; Naresh KN; Evens AM; Chadburn A; Gordon LI; Czader MB; Gill JI; Hsi ED; Greenough A; Moffitt AB; McKinney M; Banerjee A; Grubor V; Levy S; Dunson DB; Dave SS
Nat Genet; 2012 Dec; 44(12):1321-5. PubMed ID: 23143597
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.
Kaymaz Y; Oduor CI; Yu H; Otieno JA; Ong'echa JM; Moormann AM; Bailey JA
Mol Cancer Res; 2017 May; 15(5):563-576. PubMed ID: 28465297
[TBL] [Abstract][Full Text] [Related]
23. The whole-genome landscape of Burkitt lymphoma subtypes.
Panea RI; Love CL; Shingleton JR; Reddy A; Bailey JA; Moormann AM; Otieno JA; Ong'echa JM; Oduor CI; Schroeder KMS; Masalu N; Chao NJ; Agajanian M; Major MB; Fedoriw Y; Richards KL; Rymkiewicz G; Miles RR; Alobeid B; Bhagat G; Flowers CR; Ondrejka SL; Hsi ED; Choi WWL; Au-Yeung RKH; Hartmann W; Lenz G; Meyerson H; Lin YY; Zhuang Y; Luftig MA; Waldrop A; Dave T; Thakkar D; Sahay H; Li G; Palus BC; Seshadri V; Kim SY; Gascoyne RD; Levy S; Mukhopadyay M; Dunson DB; Dave SS
Blood; 2019 Nov; 134(19):1598-1607. PubMed ID: 31558468
[TBL] [Abstract][Full Text] [Related]
24. Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.
Yoon J; Yun JW; Jung CW; Ju HY; Koo HH; Kim SH; Kim HJ
Genes Chromosomes Cancer; 2020 Apr; 59(4):255-260. PubMed ID: 31705772
[TBL] [Abstract][Full Text] [Related]
25. MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.
Mazzoccoli L; Robaina MC; Apa AG; Bonamino M; Pinto LW; Queiroga E; Bacchi CE; Klumb CE
J Cancer Res Clin Oncol; 2018 Mar; 144(3):483-497. PubMed ID: 29318382
[TBL] [Abstract][Full Text] [Related]
26. Update on Burkitt Lymphoma.
Dunleavy K; Little RF; Wilson WH
Hematol Oncol Clin North Am; 2016 Dec; 30(6):1333-1343. PubMed ID: 27888884
[TBL] [Abstract][Full Text] [Related]
27. Sporadic Burkitt lymphomas of children and adolescents in Chinese: a clinicopathological study of 43 cases.
Bi CF; Tang Y; Zhang WY; Zhao S; Wang XQ; Yang QP; Li GD; Liu WP
Diagn Pathol; 2012 Jun; 7():72. PubMed ID: 22726497
[TBL] [Abstract][Full Text] [Related]
28. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age.
Burkhardt B; Michgehl U; Rohde J; Erdmann T; Berning P; Reutter K; Rohde M; Borkhardt A; Burmeister T; Dave S; Tzankov A; Dugas M; Sandmann S; Fend F; Finger J; Mueller S; Gökbuget N; Haferlach T; Kern W; Hartmann W; Klapper W; Oschlies I; Richter J; Kontny U; Lutz M; Maecker-Kolhoff B; Ott G; Rosenwald A; Siebert R; von Stackelberg A; Strahm B; Woessmann W; Zimmermann M; Zapukhlyak M; Grau M; Lenz G
Nat Commun; 2022 Jul; 13(1):3881. PubMed ID: 35794096
[TBL] [Abstract][Full Text] [Related]
29. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
Haralambieva E; Boerma EJ; van Imhoff GW; Rosati S; Schuuring E; Müller-Hermelink HK; Kluin PM; Ott G
Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
[TBL] [Abstract][Full Text] [Related]
30. Burkitt's lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes.
Klein U; Klein G; Ehlin-Henriksson B; Rajewsky K; Küppers R
Mol Med; 1995 Jul; 1(5):495-505. PubMed ID: 8529116
[TBL] [Abstract][Full Text] [Related]
31. ID3 mutations are recurrent events in double-hit B-cell lymphomas.
Gebauer N; Bernard V; Feller AC; Merz H
Anticancer Res; 2013 Nov; 33(11):4771-8. PubMed ID: 24222112
[TBL] [Abstract][Full Text] [Related]
32. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.
Rohde M; Bonn BR; Zimmermann M; Lange J; Möricke A; Klapper W; Oschlies I; Szczepanowski M; Nagel I; Schrappe M; ; ; Loeffler M; Siebert R; Reiter A; Burkhardt B
Haematologica; 2017 Jun; 102(6):1091-1098. PubMed ID: 28209658
[TBL] [Abstract][Full Text] [Related]
33. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
[TBL] [Abstract][Full Text] [Related]
34. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
[TBL] [Abstract][Full Text] [Related]
35. The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS.
Hüttl KS; Staiger AM; Richter J; Ott MM; Kalmbach S; Klapper W; Biesdorf AS; Trümper L; Rosenwald A; Ziepert M; Horn H; Ott G
Virchows Arch; 2021 Sep; 479(3):575-583. PubMed ID: 33655392
[TBL] [Abstract][Full Text] [Related]
36. The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma.
Wagener R; Aukema SM; Schlesner M; Haake A; Burkhardt B; Claviez A; Drexler HG; Hummel M; Kreuz M; Loeffler M; Rosolowski M; López C; Möller P; Richter J; Rohde M; Betts MJ; Russell RB; Bernhart SH; Hoffmann S; Rosenstiel P; Schilhabel M; Szczepanowski M; Trümper L; Klapper W; Siebert R; ;
Genes Chromosomes Cancer; 2015 Sep; 54(9):555-64. PubMed ID: 26173642
[TBL] [Abstract][Full Text] [Related]
37. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.
Hutchison RE; Finch C; Kepner J; Fuller C; Bowman P; Link M; Schwenn M; Laver J; Desai S; Barrett D; Murphy SB
Ann Oncol; 2000; 11 Suppl 1():35-8. PubMed ID: 10707776
[TBL] [Abstract][Full Text] [Related]
38. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.
Tamaru J; Hummel M; Marafioti T; Kalvelage B; Leoncini L; Minacci C; Tosi P; Wright D; Stein H
Am J Pathol; 1995 Nov; 147(5):1398-407. PubMed ID: 7485402
[TBL] [Abstract][Full Text] [Related]
39. TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma.
Teitell MA; Lones MA; Perkins SL; Sanger WG; Cairo MS; Said JW
Am J Clin Pathol; 2005 Oct; 124(4):569-75. PubMed ID: 16146820
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like Growth Factor 1 Promotes Cell Proliferation by Downregulation of G-Protein-Coupled Receptor 17 Expression via PI3K/Akt/FoxO1 Signaling in SK-N-SH Cells.
Lin KN; Zhang K; Zhao W; Huang SY; Li H
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
